Discover the insights you need to make better decisions today, to shape the future with confidence.
See more
Services
EY helps clients create long-term value for all stakeholders. Enabled by data and technology, our services and solutions provide trust through assurance and help clients transform, grow and operate.
Spotlight
Industries
Discover how EY insights and services are helping to reframe the future of your industry.
See more
Case studies
About us
At EY, our purpose is building a better working world. The insights and services we provide help to create long-term value for clients, people and society, and to build trust in the capital markets.
See more
Top news
Press release
10 Sept 2025
Press release
EY Australia announces $2.72 billion in revenue, down 2.9% from previous year
27 Aug 2025
Press release
New EY survey: Most Australians use AI at work, but few feel supported by leadership
25 Aug 2025
Recent Searches
Trending
How a license to lead can transform human potential in an AI world
Learn more about the EY AI Sentiment Index Study and unlock key insights to lead in the AI era.
09 Apr 2025 AI
How will your decisions today shape the future for generations to come?
Discover how shifts in demographics and tech reshape priorities, urging new models for growth through innovative organizational strategies. Read more.
16 Jan 2025 Innovation Realized
Amid disruption, how can legal departments innovate with confidence?
To play a more strategic and impactful role, legal departments must evolve. Explore the 2025 EY Law Study and learn how.
09 Apr 2025 LawThe need for innovation to achieve future growth targets will drive the biopharma M&A activities, mainly strategic partnerships and bolt-on acquisitions.
EY-Parthenon Global Life Sciences Deals Leader
Committed to helping life sciences companies create focused business models that outperform. Loves road trips and the outdoors.
Subin is a partner at Ernst & Young LLP and the EY-Parthenon Global Life Sciences Deals Leader. He has more than a decade of transaction experience, helping life sciences companies with transformational transactions.
Subin has extensive global experience serving as a buy- and sell-side transaction advisor for Fortune 500 companies, including in corporate and private equity. His experience includes working with companies in the pharmaceutical, medical device and biotechnology subsectors.
Subin focuses on acquisitions, carve-outs, spin-offs and initial public offerings and works with companies at all stages of maturity, from startups to public companies. He frequently speaks at life sciences events about sector trends and acquisitions and divestitures topics.
He received his Master of Commerce from Macquarie University in Sydney, Australia. He is a chartered accountant from the Institute of Chartered Accountants of Australia and New Zealand.
"I am helping to build a better working world by advising global life sciences companies of all sizes on how to remain agile at a time of dynamic change. By asking better questions, I work closely alongside these companies to help them create new high-growth investment and portfolio optimization opportunities."